|
ABL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.782600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.904300E-02 |
| Normal-vs-Stage2 |
4.862000E-01 |
| Normal-vs-Stage3 |
6.069400E-01 |
| Normal-vs-Stage4 |
9.722100E-02 |
| Stage1-vs-Stage2 |
6.938300E-02 |
| Stage1-vs-Stage3 |
2.235700E-02 |
| Stage1-vs-Stage4 |
3.159100E-03 |
| Stage2-vs-Stage3 |
7.616400E-01 |
| Stage2-vs-Stage4 |
4.910200E-01 |
| Stage3-vs-Stage4 |
2.317000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.487000E-01 |
| Normal-vs-AfricanAmerican |
1.295640E-02 |
| Normal-vs-Asian |
1.155380E-01 |
| Caucasian-vs-AfricanAmerican |
6.835500E-03 |
| Caucasian-vs-Asian |
1.583620E-02 |
| AfricanAmerican-vs-Asian |
8.058600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.999770E-01 |
| Normal-vs-Female |
5.381100E-03 |
| Male-vs-Female |
1.97543000000078E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.884230E-01 |
| Normal-vs-Age(41-60Yrs) |
2.590600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.524600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.968200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.000400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.089900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.667550E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.987700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.307000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.659400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.331600E-02 |
| Normal-vs-Grade 2 |
1.141250E-01 |
| Normal-vs-Grade 3 |
1.593020E-01 |
| Normal-vs-Grade 4 |
7.623400E-01 |
| Grade 1-vs-Grade 2 |
3.769900E-02 |
| Grade 1-vs-Grade 3 |
1.484340E-02 |
| Grade 1-vs-Grade 4 |
2.075700E-02 |
| Grade 2-vs-Grade 3 |
1.342660E-03 |
| Grade 2-vs-Grade 4 |
1.347390E-01 |
| Grade 3-vs-Grade 4 |
5.113200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.903780E-01 |
| Normal-vs-ccB subtype |
7.604800E-01 |
| ccA subtype-vs-ccB subtype |
1.315970E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.061200E-01 |
| Normal-vs-N1 |
7.743200E-01 |
| N0-vs-N1 |
8.148600E-01 |
|
|
